U.K. shares keep gaining

U.K. biotech shares, as tracked by the BioCentury London Index, gained 11% in the third quarter, from 1052 at June 30 to 1166 at Sept. 29. The combined market cap of the 14 stocks in the index rose £700 million to £7 billion ($10.2 billion).

Europe: Don't look down

Stephen Parker, director of corporate finance with Altium Capital, sees a